Here in this article, DDR and its role in cancer therapy will be briefly reviewed, then we will recapitulate the preclinical studies pointing to the potential of DDR targeting in OCCC treatment, with emphasis on the role of ARID1A in DDR. Here, ARID1A is linked to cancer.